Related Experiment Video
Updated: Jan 14, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Short- and long-term effects of transfusion in β-thalassemia: a longitudinal study of transfusion efficiency factors
Konstantina Theocharaki1, Ioanna Barla2, Sophia Delicou3
1Department of Biology, School of Science, National and Kapodistrian University of Athens, Athens, Greece.
The complex interplay between donor and recipient factors likely influences transfusion outcomes in transfusion-dependent thalassemia (TDT). We investigated physiological responses to transfusion shortly after it and 1 week later, focusing on hemoglobin (Hb) increment (ΔHb) and its determinants, using longitudinal data from 36 patients with TDT and 58 red blood cell (RBC) units. Immediate anemia correction after transfusion was associated with decreases in platelets and nucleated RBCs, increases in ADAMTS13 antigen and plasma amino acid levels, and temporary rises in hemolysis and phthalates. One week after transfusion, at the peak of erythroid suppression, plasma antioxidants and mechanical hemolysis decreased, whereas proteasome activity at the RBC membrane increased. Leukocyte levels declined, markers of thrombotic risk and endothelium dysfunction improved, and hepcidin as well as plasma glutamine and deoxyadenosine, increased. In addition to female sex and anemia, ΔHb was influenced by recipient baseline monocyte levels, hypercoagulability, and plasma metabolites, such as methionine, adenosine, acyl-carnitines, and bile acids. Donor RBC unit factors, including residual platelet levels, RBC proteasome activity, arginine metabolism, and catecholamine content also had significant correlations. Notably, the baseline neutrophil-to-lymphocyte ratio strongly affected ΔHb soon after transfusion, after adjusting for confounders. At the 1-week mark, ΔHb correlated with storability markers, such as oxidative hemolysis and phthalates, which, to our knowledge, is a first-ever described connection. Importantly, the percentage of phosphatidylserine-exposing donor RBCs and the uric acid-dependent antioxidant capacity of the RBC units significantly influenced ΔHb at the 1-week time point. These findings enhance our understanding of transfusion dynamics, paving the way for more personalized and effective care strategies in TDT management.
The complex interplay between donor and recipient factors likely influences transfusion outcomes in transfusion-dependent thalassemia (TDT). We investigated physiological responses to transfusion shortly after it and 1 week later, focusing on hemoglobin (Hb) increment (ΔHb) and its determinants, using longitudinal data from 36 patients with TDT and 58 red blood cell (RBC) units. Immediate anemia correction after transfusion was associated with decreases in platelets and nucleated RBCs, increases in ADAMTS13 antigen and plasma amino acid levels, and temporary rises in hemolysis and phthalates. One week after transfusion, at the peak of erythroid suppression, plasma antioxidants and mechanical hemolysis decreased, whereas proteasome activity at the RBC membrane increased. Leukocyte levels declined, markers of thrombotic risk and endothelium dysfunction improved, and hepcidin as well as plasma glutamine and deoxyadenosine, increased. In addition to female sex and anemia, ΔHb was influenced by recipient baseline monocyte levels, hypercoagulability, and plasma metabolites, such as methionine, adenosine, acyl-carnitines, and bile acids. Donor RBC unit factors, including residual platelet levels, RBC proteasome activity, arginine metabolism, and catecholamine content also had significant correlations. Notably, the baseline neutrophil-to-lymphocyte ratio strongly affected ΔHb soon after transfusion, after adjusting for confounders. At the 1-week mark, ΔHb correlated with storability markers, such as oxidative hemolysis and phthalates, which, to our knowledge, is a first-ever described connection. Importantly, the percentage of phosphatidylserine-exposing donor RBCs and the uric acid-dependent antioxidant capacity of the RBC units significantly influenced ΔHb at the 1-week time point. These findings enhance our understanding of transfusion dynamics, paving the way for more personalized and effective care strategies in TDT management.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Oxygen Transport in the Blood